Ulrich Müller-Sedgwick

Ulrich Müller-Sedgwick

University of Cambridge

H-index: 58

Europe-United Kingdom

About Ulrich Müller-Sedgwick

Ulrich Müller-Sedgwick, With an exceptional h-index of 58 and a recent h-index of 29 (since 2020), a distinguished researcher at University of Cambridge, specializes in the field of ADHD, neuropsychiatry, pharmacological neuroimaging, psychopharmacology, schizophrenia.

His recent articles reflect a diverse array of research interests and contributions to the field:

UK adult ADHD services in crisis

ADHD: how can the NHS deliver better provision?

Assessments for adult ADHD: what makes them good enough?

Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention …

OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16-25 years: a RCT

University students with attention deficit hyperactivity disorder (ADHD): a consensus statement from the UK Adult ADHD Network (UKAAN)

ADHD Remote Technology study of cardiometabolic risk factors and medication adherence (ART-CARMA): a multi-centre prospective cohort study protocol

Private healthcare pressures on GPs: ADHD deserves better

Ulrich Müller-Sedgwick Information

University

Position

BEH Mental Health NHS Trust (North London) & Department of Psychiatry

Citations(all)

11941

Citations(since 2020)

3902

Cited By

9608

hIndex(all)

58

hIndex(since 2020)

29

i10Index(all)

108

i10Index(since 2020)

72

Email

University Profile Page

University of Cambridge

Google Scholar

View Google Scholar Profile

Ulrich Müller-Sedgwick Skills & Research Interests

ADHD

neuropsychiatry

pharmacological neuroimaging

psychopharmacology

schizophrenia

Top articles of Ulrich Müller-Sedgwick

Title

Journal

Author(s)

Publication Date

UK adult ADHD services in crisis

BJPsych Bulletin

Michael CF Smith

Raja AS Mukherjee

Ulrich Müller-Sedgwick

Dietmar Hank

Peter Carpenter

...

2024/2

ADHD: how can the NHS deliver better provision?

bmj

Laurence Leaver

Ulrich Müller-Sedgwick

Kobus van Rensburg

2024/1/29

Assessments for adult ADHD: what makes them good enough?

British Journal of General Practice

Laurence Leaver

Kobus van Rensburg

Marios Adamou

Muhammad Arif

Philip Asherson

...

2023/10/1

Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention …

The British Journal of Psychiatry

Philip J Asherson

Lena Johansson

Rachel Holland

Megan Bedding

Andrew Forrester

...

2023/1

OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16-25 years: a RCT

Philip Asherson

Lena Johansson

Rachel Holland

Megan Bedding

Andrew Forrester

...

2022/6/30

University students with attention deficit hyperactivity disorder (ADHD): a consensus statement from the UK Adult ADHD Network (UKAAN)

BMC psychiatry

Jane A Sedgwick-Müller

Ulrich Müller-Sedgwick

Marios Adamou

Marco Catani

Rebecca Champ

...

2022/4/22

ADHD Remote Technology study of cardiometabolic risk factors and medication adherence (ART-CARMA): a multi-centre prospective cohort study protocol

BMC psychiatry

Hayley Denyer

J Antoni Ramos-Quiroga

Amos Folarin

Carolina Ramos

Petra Nemeth

...

2022/12/20

Private healthcare pressures on GPs: ADHD deserves better

bmj

Laurence Leaver

Ulrich Müller-Sedgwick

2022/11/10

Mainstreaming adult ADHD into primary care in the UK: guidance, practice, and best practice recommendations

BMC psychiatry

Philip Asherson

Laurence Leaver

Marios Adamou

Muhammad Arif

Gemma Askey

...

2022/10/11

Recommendations for occupational therapy interventions for adults with ADHD: a consensus statement from the UK adult ADHD network

Marios Adamou

Philip Asherson

Muhammad Arif

Louise Buckenham

Sally Cubbin

...

2021/12

What is the optimal dosing interval for Covid-19 vaccines? We need clinical trial evidence and consider past infection

BMJ Rapid Response letter

Ulrich Müller-Sedgwick

2021

Drugs to treat attention deficit hyperactivity disorder (ADHD)

Ulrich Müller-Sedgwick

Jane Ann Sedgwick-Müller

2020

See List of Professors in Ulrich Müller-Sedgwick University(University of Cambridge)

Co-Authors

H-index: 261
Prof. T.W. Robbins

Prof. T.W. Robbins

University of Cambridge

H-index: 165
Barbara J Sahakian

Barbara J Sahakian

University of Cambridge

H-index: 139
Klaus-Peter Lesch

Klaus-Peter Lesch

Julius-Maximilians-Universität Würzburg

H-index: 110
John Suckling

John Suckling

University of Cambridge

H-index: 104
Danielle (Dani) S. Bassett

Danielle (Dani) S. Bassett

University of Pennsylvania

H-index: 86
Gisli Gudjonsson

Gisli Gudjonsson

King's College London

academic-engine